FDA Goes Straight To Final Guidance For Generic Chloroquine

Allows Quick Coronavirus Response As Agency Also Issues Hydroxychloroquine Guidance

Product-specific guidances for generic versions of chloroquine and hydroxychloroquine have been issued by the FDA. Final guidance for chloroquine has been published without a draft version due to the need for speedy action amid the COVID-19 outbreak.

Hydroxychloroquine
Guidance for developing generic versions of chloroquine and hydroxychloroquine has been issued • Source: Shutterstock

More from Regulation

More from Policy & Regulation